Geoffrey Wells (Geoff Wells)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Journal of medicinal chemistry

Biochemical Society transactions

Nature reviews. Drug discovery

International journal of nanomedicine

Pharminox Ltd

University of Nottingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pharminox Ltd Aug 20 2005 - Oct 14 2007

United Kingdom

Drug Discovery Project Leader

University of London Jul 01 2001 - Jul 01 2005

United Kingdom

Post-Doctoral Research Fellow :: School of Pharmacy

University of Nottingham Feb 01 1999 - Jul 01 2001

United Kingdom

Post-Doctoral Research Associate :: Cancer Research Laboratories

Education History

University of Nottingham Oct 01 1994 - Jul 01 1998

United Kingdom

PHD :: Cancer Research Laboratories

Publications

Uzma Jaffry, Geoffrey Wells
Small molecule and peptide inhibitors of βTrCP and the βTrCP-NRF2 protein-protein interaction. Biochemical Society transactions (2023)
Nikolaos Georgakopoulos, Sandeep Talapatra, Dina Dikovskaya, Sharadha Dayalan Naidu, Maureen Higgins, Jemma Gatliff, Aysel Ayhan, Roxani Nikoloudaki, Marjolein Schaap, Klara Valko, Farideh Javid, Albena T Dinkova-Kostova, Frank Kozielski, Geoffrey Wells
Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding Mode. Journal of medicinal chemistry 65 (10) (2022)
Andreas R Kiessling, Sarah A Harris, Kathleen M Weimer, Geoffrey Wells, Adrian Goldman
The C-terminal head domain of Burkholderia pseudomallei BpaC has a striking hydrophilic core with an extensive solvent network. Molecular microbiology 118 (1-2) (2022)
Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, Marcos Morales-Tenorio, Ángeles Martín-Requero, Gracia Porras, Ana Martinez, Giorgio Giorgi, Pilar López-Alvarado, Isabel Lastres-Becker, José Carlos Menéndez
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. Journal of medicinal chemistry 65 (3) (2022)
Kit-Kay Mak, Shiming Zhang, Ola Epemolu, Albena T Dinkova-Kostova, Geoffrey Wells, Irina G Gazaryan, Raghavendra Sakirolla, Zulkefeli Mohd, Mallikarjuna Rao Pichika
Synthesis and Anti-Inflammatory Activity of 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-Derived NRF2 Activators. ChemistryOpen 11 (10) (2022)
Kavit H S Main, James Iain Provan, Philip J Haynes, Geoffrey Wells, John A Hartley, Alice L B Pyne
Atomic force microscopy-A tool for structural and translational DNA research. APL bioengineering 5 (3) (2021)
Yuta Horie, Takafumi Suzuki, Jin Inoue, Tatsuro Iso, Geoffrey Wells, Terry W Moore, Tsunehiro Mizushima, Albena T Dinkova-Kostova, Takuma Kasai, Takashi Kamei, Seizo Koshiba, Masayuki Yamamoto
Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism. Communications biology 4 (1) (2021)
Dénes Berta, Magd Badaoui, Sam Alexander Martino, Pedro J Buigues, Andrei V Pisliakov, Nadia Elghobashi-Meinhardt, Geoffrey Wells, Sarah A Harris, Elisa Frezza, Edina Rosta
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design. Chemical science 12 (40) (2021)
Alastair F Breen, David J Scurr, Maria Letizia Cassioli, Geoffrey Wells, Neil R Thomas, Jihong Zhang, Lyudmila Turyanska, Tracey D Bradshaw
Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery. International journal of nanomedicine 14 (2019)
Antonio Cuadrado, Ana I Rojo, Geoffrey Wells, John D Hayes, Sharon P Cousin, William L Rumsey, Otis C Attucks, Stephen Franklin, Anna-Liisa Levonen, Thomas W Kensler, Albena T Dinkova-Kostova
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature reviews. Drug discovery 18 (4) (2019)
Nikolaos D Georgakopoulos, Sandeep K Talapatra, Jemma Gatliff, Frank Kozielski, Geoffrey Wells
Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids. Chembiochem : a European journal of chemical biology 19 (17) (2018)

Geoffrey Wells.css-eqlu8i{font-size:small;padding-left:4px;} (Geoff Wells)

Publication Activity (10 Years)

Top Topics

Top Venues

Geoffrey Wells (Geoff Wells)